Critical Care. Optimized.
Consano Medical is an early clinical-stage medical device company focused on the development of a minimally-invasive intelligent monitoring device that is expected to become standard of care in the ICU.
Consano Medical recently received two NIH grants for further device development, pre-clinical testing and clinical testing and is currently seeking Series A financing to continue the clinical development of their OmniSense® monitoring device*. This technology utilizes the urinary drainage catheter found in all ICU patients to extract valuable clinical data that has the potential to save lives by providing earlier diagnosis of Sepsis or Systemic Inflammatory Response Syndrome (SIRS) and optimizing its treatment by detecting and preventing fluid overload during fluid resuscitation.
*The Consano Medical OmniSense® monitoring device is not available for sale or use within the United States or internationally.